Ligand Pharmaceuticals Incorporated Logo

Ligand Pharmaceuticals Incorporated (LGND)

NASDAQ

Currency in USD
303.53
-4.29 (-1.39%)

Closed

Oct 23, 2026

Day's Range

302.37
313.28

52 wk Range

175.89
326.63

Profile - LGND - Ligand Pharmaceuticals Incorporated

Profile

Mic Code

XNMS

Sector

Healthcare

Industry

Biotechnology

Employees

47


Ligand Pharmaceuticals Incorporated is a biopharmaceutical company that focuses on developing and licensing technologies and assets that support the discovery and development of medicines. Ligand Pharmaceuticals Incorporated operates a royalty-driven business model, partnering with other biopharmaceutical companies to finance and advance late-stage clinical programs while also managing a broad portfolio of royalty interests. Its current portfolio spans commercial, clinical, and preclinical-stage assets across multiple therapeutic areas, including infectious diseases, oncology, respiratory conditions, kidney disease, and rare diseases. The company also works through technology licensing and asset acquisition activities to expand the range of medicines connected to its platform. Based in Jupiter, Florida, Ligand Pharmaceuticals Incorporated plays a specialized role in the life sciences market by providing capital, expertise, and royalty management across a diversified set of partnered drug programs.

Profile Details

Type

Common Stock

Address

555 Heritage Drive

City

Jupiter

State

FL

Zip

33458

Country

United States

Phone

858 550 7500

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.